-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The chemical industry is one of the most important sectors of the modern world, providing a wide range of products that are crucial for various industries, including pharmaceuticals, cosmetics, food and beverages, and textiles.
In this sector, there is a constant demand for new chemical compounds that can be used in various applications.
One such compound is N-(8-amino-6-fluoro-5-methyl-1-oxo-1,2,3,4-tetrahydronaphthalen-2-yl)acetamide, which is commonly referred to as AFN-1221.
AFN-1221 is a unique compound that has shown promising results in various studies.
It is known to have antiviral properties, making it a potential treatment for viral infections such as COVID-19.
Additionally, it has been shown to have anti-inflammatory effects, which could make it useful in treating conditions such as arthritis.
AFN-1221 is also being studied for its potential to treat certain types of cancer.
AFN-1221 is synthesized through a multi-step process that involves a number of chemical reactions.
The synthesis of AFN-1221 begins with the reaction of 2-fluor-6-methyl-1,3-oxazepan-3-one with sodium hydroxide, which forms the intermediate compound 2-fluor-6-methyl-1,3-oxazepan-3-ol.
This is then reduced with lithium aluminum hydride to form 6-fluoro-5-methyl-1,3-oxazepan-2-one.
The next step in the synthesis of AFN-1221 involves the reaction of 6-fluoro-5-methyl-1,3-oxazepan-2-one with acetylene oxide to form the compound N-(8-amino-6-fluoro-5-methyl-1-oxo-1,2,3,4-tetrahydronaphthalen-2-yl)acetamide.
This compound is then converted into the hydrochloride salt form, which is the final product.
The synthesis of AFN-1221 can be conducted using standard chemical techniques and equipment.
However, it is important to note that the synthesis of this compound requires the handling of potentially hazardous chemicals, and proper safety protocols must be in place to prevent accidents or injuries.
AFN-1221 has shown promising results in clinical trials, indicating that it may be an effective treatment for a variety of viral infections, inflammatory conditions, and types of cancer.
As more research is conducted on this compound, it is likely that its potential uses will become even more apparent.
AFN-1221 is a prime example of the importance of innovation in the chemical industry.
Without the constant development of new compounds, the treatment of viral infections, inflammatory conditions, and cancer would be limited.
AFN-1221 has the potential to revolutionize the treatment of these conditions, and it is likely that similar compounds will be developed in the future.
AFN-1221 is also an example of the delicate balance between innovation and safety.
The synthesis of this compound requires the handling of potentially hazardous chemicals, and proper safety protocols must be in place to prevent accidents or injuries.
It is important for the chemical industry to prioritize safety while also pushing the boundaries of innovation.
In conclusion, N-(8-amino-6-fluoro-5-methyl-1-oxo-1,2,3,4-tetrahydronaphthalen-2-yl)acetamide, or AFN-1221, is a promising new compound with potential applications in the treatment of viral infections, inflammatory conditions, and certain types of cancer.
Its synthesis involves a number of chemical reactions, and proper safety protocols must be in place to prevent accidents or injuries during the synthesis process.
As more research is conducted on AFN-